UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039631
Receipt number R000045201
Scientific Title A confirmatory, self-controlled study of peripheral skin temperature-decreasing effect of elastic compression gloves and stockings in healthy volunteers
Date of disclosure of the study information 2020/03/01
Last modified on 2020/03/07 06:25:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A confirmatory, self-controlled study of peripheral skin temperature-decreasing effect of elastic compression gloves and stockings in healthy volunteers

Acronym

A confirmatory, self-controlled study of peripheral skin temperature-decreasing effect of elastic compression gloves and stockings in healthy volunteers

Scientific Title

A confirmatory, self-controlled study of peripheral skin temperature-decreasing effect of elastic compression gloves and stockings in healthy volunteers

Scientific Title:Acronym

A confirmatory, self-controlled study of peripheral skin temperature-decreasing effect of elastic compression gloves and stockings in healthy volunteers

Region

Japan


Condition

Condition

Normal healthy volunteers

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Confirm peripheral skin temperature-decreasing effect of elastic compression gloves and stockings (ECGS) in healthy volunteers

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Peripheral skin temperature (hands and foot) 2 hours after compression using ECGS

Key secondary outcomes

Compression measurement
Blood pressure in the lower legs
SpO2


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

Compression with ECGS on the hand and leg of the intervention side, and wearing the glove and stocking without compression on the control side for 2 hours

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

60 years-old >=

Gender

Male and Female

Key inclusion criteria

1,Japanese healthy adult men and women aged from 30 to 60 years old at the time of the screening
2,A person who is judged eligible for the study subject by the investigator or sub-investigator based on a result of the screening
3,Applicants who have been fully informed about the purpose and contents of this medical device and this study (including restrictions on subjects and others), and have given written consent to participate in the study on their own initiative

Key exclusion criteria

1,A person who has a current disease
2,A person having medical history (such as diseases of the heart, liver, kidney, lung, blood) that is considered inappropriate for this study
3,A person who is currently participating in other clinical studies
4,A person who received a drug product in the participation in a Phase I clinical study within 16 weeks before this study, or in the participation in a clinical study within 12 weeks before this study
5,A person who is considered inappropriate by the investigators (examples: in case there are signs of peripheral circulatory insufficiency such as Raynaud phenomenon, or there is a rash requiring treatment, etc.)
6,A person who does not have the appropriate size in the prepared gloves and stockings, or that whose stocking size is SS.

Target sample size

8


Research contact person

Name of lead principal investigator

1st name Nobuko
Middle name
Last name KAWAGUCHI

Organization

Kyoto University Hospital

Division name

Clinical oncology

Zip code

606-8397

Address

54 Shogoin Kawara-cho Sakyo-ku, Kyoto

TEL

075-751-3111

Email

nobuko75@kuhp.kyoto-u.ac.jp


Public contact

Name of contact person

1st name Kazuhiko
Middle name
Last name TAKANO

Organization

Medical Corporation Hokubukai UTSUKUSHIGAOKA Hospital Clinical Pharmacology Center

Division name

Pharmacology Center, interlocking head

Zip code

004-0839

Address

61-1 Kiyota-ku, Shin-ei, Sapporo-shi, Hokkaido

TEL

011-882-0111

Homepage URL


Email

info@ughp-cpc.jp


Sponsor or person

Institute

Medical Corporation Hokubukai
Utsukushigaoka Hospital Clinical Pharmacology Center

Institute

Department

Personal name



Funding Source

Organization

AMED

Organization

Division

Category of Funding Organization

Government offices of other countries

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Utsukushigaoka Hospital IRB

Address

61-1 Kiyota-ku, Shin-ei, Sapporo-shi, Hokkaido

Tel

011-882-0111

Email

info@ughp-cpc.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

医療法人北武会美しが丘病院臨床薬理センター(北海道)


Other administrative information

Date of disclosure of the study information

2020 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 02 Month 17 Day

Date of IRB

2020 Year 02 Month 20 Day

Anticipated trial start date

2020 Year 03 Month 02 Day

Last follow-up date

2020 Year 03 Month 07 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 02 Month 28 Day

Last modified on

2020 Year 03 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045201


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name